$CLIR
ClearSign Technologies Corp

2022 Q4 Form 10-Q Financial Statement

#000155837022017750 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $50.00K $324.0K
YoY Change -7.41% 70.53%
Cost Of Revenue $57.00K $201.0K
YoY Change 11.76% -27.7%
Gross Profit -$7.000K $123.0K
YoY Change -333.33% -239.77%
Gross Profit Margin -14.0% 37.96%
Selling, General & Admin $1.386M $1.461M
YoY Change 40.85% 29.18%
% of Gross Profit 1187.8%
Research & Development $112.0K $97.00K
YoY Change -54.1% -91.48%
% of Gross Profit 78.86%
Depreciation & Amortization $48.00K $41.00K
YoY Change 6.67% -66.67%
% of Gross Profit 33.33%
Operating Expenses $1.498M $1.558M
YoY Change 21.99% -31.34%
Operating Profit -$1.505M -$1.435M
YoY Change 22.86% -39.12%
Interest Expense $48.00K $35.00K
YoY Change 4700.0%
% of Operating Profit
Other Income/Expense, Net $138.0K $123.0K
YoY Change -44.35% 2975.0%
Pretax Income -$1.318M -$1.312M
YoY Change 7.42% -44.24%
Income Tax
% Of Pretax Income
Net Earnings -$1.318M -$1.312M
YoY Change 7.42% -44.24%
Net Earnings / Revenue -2636.0% -404.94%
Basic Earnings Per Share -$0.03 -$0.03
Diluted Earnings Per Share -$0.03 -$0.03
COMMON SHARES
Basic Shares Outstanding 38.02M 37.95M
Diluted Shares Outstanding 37.87M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.057M $9.780M
YoY Change 19.06% 10.62%
Cash & Equivalents $6.451M $5.880M
Short-Term Investments $2.606M $3.900M
Other Short-Term Assets $577.0K $506.0K
YoY Change 67.25% 678.46%
Inventory
Prepaid Expenses
Receivables $79.00K $38.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $9.733M $10.61M
YoY Change 21.3% 14.11%
LONG-TERM ASSETS
Property, Plant & Equipment $384.0K $427.0K
YoY Change -27.55% -35.01%
Goodwill
YoY Change
Intangibles $798.0K $818.0K
YoY Change -0.13% -13.16%
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $1.192M $1.255M
YoY Change -10.98% -22.0%
TOTAL ASSETS
Total Short-Term Assets $9.733M $10.61M
Total Long-Term Assets $1.192M $1.255M
Total Assets $10.93M $11.86M
YoY Change 16.68% 8.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $296.0K $287.0K
YoY Change 32.14% 4.74%
Accrued Expenses $471.0K $300.0K
YoY Change 116.06% -50.5%
Deferred Revenue $247.0K $61.00K
YoY Change 194.05%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.147M $828.0K
YoY Change 56.91% -23.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $226.0K $239.0K
YoY Change -35.43% -40.69%
Total Long-Term Liabilities $226.0K $239.0K
YoY Change -35.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.147M $828.0K
Total Long-Term Liabilities $226.0K $239.0K
Total Liabilities $1.373M $1.067M
YoY Change 27.01% -28.15%
SHAREHOLDERS EQUITY
Retained Earnings -$88.50M -$87.20M
YoY Change 6.93% 6.94%
Common Stock $4.000K $4.000K
YoY Change 33.33% 33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.552M $10.80M
YoY Change
Total Liabilities & Shareholders Equity $10.93M $11.86M
YoY Change 16.68% 8.78%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$1.318M -$1.312M
YoY Change 7.42% -44.24%
Depreciation, Depletion And Amortization $48.00K $41.00K
YoY Change 6.67% -66.67%
Cash From Operating Activities -$728.0K -$917.0K
YoY Change -37.51% -50.91%
INVESTING ACTIVITIES
Capital Expenditures $45.00K -$41.00K
YoY Change -157.69% 0.0%
Acquisitions
YoY Change
Other Investing Activities $1.341M -$3.900M
YoY Change
Cash From Investing Activities $1.296M -$3.941M
YoY Change -1761.54% 9512.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.741M
YoY Change 1512.04%
NET CHANGE
Cash From Operating Activities -728.0K -917.0K
Cash From Investing Activities 1.296M -3.941M
Cash From Financing Activities 0.000 1.741M
Net Change In Cash 568.0K -3.117M
YoY Change -145.7% 73.07%
FREE CASH FLOW
Cash From Operating Activities -$728.0K -$917.0K
Capital Expenditures $45.00K -$41.00K
Free Cash Flow -$773.0K -$876.0K
YoY Change -28.89% -52.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37871291
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31491174
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34435117
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31114769
dei Entity Central Index Key
EntityCentralIndexKey
0001434524
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
clir Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
P0Y
clir Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
P0Y
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38019951
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31581666
CY2021Q3 clir Number Of Contracts Estimated Losses Included In Cost Of Sales
NumberOfContractsEstimatedLossesIncludedInCostOfSales
1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35521
dei Entity Registrant Name
EntityRegistrantName
CLEARSIGN TECHNOLOGIES CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2056298
dei Entity Address Address Line1
EntityAddressAddressLine1
8023 E. 63rd Place, Suite 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74133
dei City Area Code
CityAreaCode
918
dei Local Phone Number
LocalPhoneNumber
236-6461
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
CLIR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38019951
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5880000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7607000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
3900000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33000
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
284000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
506000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
345000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
10608000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8024000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
818000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2022Q3 us-gaap Assets
Assets
11863000
CY2021Q4 us-gaap Assets
Assets
9363000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
287000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
224000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
180000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
300000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
61000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
828000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
731000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2022Q3 us-gaap Liabilities
Liabilities
1067000
CY2021Q4 us-gaap Liabilities
Liabilities
1081000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38019951
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31581666
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98008000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91035000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-11000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87205000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82765000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
10796000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8282000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10796000
us-gaap Cost Of Revenue
CostOfRevenue
201000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11863000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9363000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
324000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
190000
us-gaap Cost Of Revenue
CostOfRevenue
1008000
CY2022Q3 us-gaap Gross Profit
GrossProfit
123000
CY2021Q3 us-gaap Gross Profit
GrossProfit
-88000
us-gaap Gross Profit
GrossProfit
123000
us-gaap Gross Profit
GrossProfit
-455000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
324000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
553000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
201000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
278000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1138000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
393000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2436000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1461000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1131000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4342000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4029000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1558000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
2269000
us-gaap Operating Expenses
OperatingExpenses
4735000
us-gaap Operating Expenses
OperatingExpenses
6465000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1435000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2357000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4612000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6920000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35000
CY2022Q3 clir Governmental Assistance Income
GovernmentalAssistanceIncome
88000
clir Governmental Assistance Income
GovernmentalAssistanceIncome
100000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
251000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
37000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
123000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
172000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
255000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-1312000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-2353000
us-gaap Profit Loss
ProfitLoss
-4440000
us-gaap Profit Loss
ProfitLoss
-6665000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1312000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2353000
us-gaap Net Income Loss
NetIncomeLoss
-4440000
us-gaap Net Income Loss
NetIncomeLoss
-6664000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37871291
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31491174
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34435117
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31114769
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022Q1 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2022Q1 clir Common Stock Issued For Exercise Of Options2.93 Per Share
CommonStockIssuedForExerciseOfOptions2.93PerShare
2.93
CY2022Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
95000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
80000
CY2022Q1 clir Share Issued For At Market Issuance1.24 Per Share
ShareIssuedForAtMarketIssuance1.24PerShare
1.24
CY2022Q1 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
578000
CY2022Q1 clir Stock Options Granted In Payment Of Accrued Compensation Fair Value
StockOptionsGrantedInPaymentOfAccruedCompensationFairValue
12000
CY2022Q1 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
CY2022Q1 clir Shares Issued For Services1.93 Per Share
SharesIssuedForServices1.93PerShare
7000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1490000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7564000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000
CY2022Q2 clir Share Issued For At Market Issuance1.71 Per Share
ShareIssuedForAtMarketIssuance1.71PerShare
1.71
CY2022Q2 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
9000
CY2022Q2 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
CY2022Q2 clir Shares Issued For Services1.93 Per Share
SharesIssuedForServices1.93PerShare
7000
CY2022Q2 clir Shares Issued Stock Offering Price Per Share
SharesIssuedStockOfferingPricePerShare
1.11
CY2022Q2 clir Stock Issued During Period Value Stock Offering
StockIssuedDuringPeriodValueStockOffering
4211000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1638000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10193000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
177000
CY2022Q3 clir Shares Issue On Cashless Exercise Price Per Share
SharesIssueOnCashlessExercisePricePerShare
0.89
CY2022Q3 clir Shares Issued Pursuant To Purchase Right Price Per Share
SharesIssuedPursuantToPurchaseRightPricePerShare
1.11
CY2022Q3 clir Shares Issued Pursuant To Purchase Right1.11 Per Share
SharesIssuedPursuantToPurchaseRight1.11PerShare
1741000
CY2022Q3 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
CY2022Q3 clir Shares Issued For Services1.93 Per Share
SharesIssuedForServices1.93PerShare
7000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-1312000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10796000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9541000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.90 Per Share
CommonStockIssuedForExerciseOfOptions1.90PerShare
1.90
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised1.90 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.90PerShare
2000
CY2021Q1 clir Common Stock Issued For Exercise Of Options3.80 Per Share
CommonStockIssuedForExerciseOfOptions3.80PerShare
3.80
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised3.80 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.80PerShare
36000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.21 Per Share
CommonStockIssuedForExerciseOfOptions1.21PerShare
1.21
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised1.21 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.21PerShare
4000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.80 Per Share
CommonStockIssuedForExerciseOfOptions1.80PerShare
1.80
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised1.80 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.80PerShare
67000
CY2021Q1 clir Adjustments To Additional Paid In Capital Share Based Payment Arrangement Option Increase For Cost Recognition Two
AdjustmentsToAdditionalPaidInCapitalShareBasedPaymentArrangementOptionIncreaseForCostRecognitionTwo
210000
CY2021Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
217000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
410000
CY2021Q1 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
4469000
CY2021Q1 clir Proceeds Receivable From At Market Issuance
ProceedsReceivableFromAtMarketIssuance
1076000
CY2021Q1 clir Shares Issued For Services Per Share
SharesIssuedForServicesPerShare
2.33
CY2021Q1 clir Shares Issued For Services2.33 Per Share
SharesIssuedForServices2.33PerShare
9000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2021000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11868000
CY2021Q2 clir Common Stock Issued For Exercise Of Options3.10 Per Share
CommonStockIssuedForExerciseOfOptions3.10PerShare
3.10
CY2021Q2 clir Stock Issued During Period Value Stock Options Exercised3.10 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.10PerShare
54000
CY2021Q2 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2021Q2 clir Stock Issued During Period Value Stock Options Exercised0.89 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised0.89PerShare
36000
CY2021Q2 clir Common Stock Issued For Exercise Of Options1.85 Per Share
CommonStockIssuedForExerciseOfOptions1.85PerShare
1.85
CY2021Q2 clir Stock Issued During Period Value Stock Options Exercised1.85 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.85PerShare
6000
CY2021Q2 clir Common Stock Issued For Exercise Of Options1.21 Per Share
CommonStockIssuedForExerciseOfOptions1.21PerShare
1.21
CY2021Q2 clir Stock Issued During Period Value Stock Options Exercised1.21 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.21PerShare
72000
CY2021Q2 clir Common Stock Issued For Exercise Of Options0.98 Per Share
CommonStockIssuedForExerciseOfOptions0.98PerShare
0.98
CY2021Q2 clir Common Stock Issued For Exercise Of Options2.93 Per Share
CommonStockIssuedForExerciseOfOptions2.93PerShare
2.93
CY2021Q2 clir Adjustments To Additional Paid In Capital Share Based Payment Arrangement Option Increase For Cost Recognition Two
AdjustmentsToAdditionalPaidInCapitalShareBasedPaymentArrangementOptionIncreaseForCostRecognitionTwo
52000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19000
CY2021Q2 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
1916000
CY2021Q2 clir Shares Issued For Services Per Share
SharesIssuedForServicesPerShare
2.33
CY2021Q2 clir Shares Issued For Services2.33 Per Share
SharesIssuedForServices2.33PerShare
9000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-2291000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11741000
CY2021Q3 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2021Q3 clir Stock Issued During Period Value Stock Options Exercised0.89 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised0.89PerShare
19000
CY2021Q3 clir Common Stock Issued For Exercise Of Options1.21 Per Share
CommonStockIssuedForExerciseOfOptions1.21PerShare
1.21
CY2021Q3 clir Stock Issued During Period Value Stock Options Exercised1.21 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.21PerShare
79000
CY2021Q3 clir Common Stock Issued For Exercise Of Options1.90 Per Share
CommonStockIssuedForExerciseOfOptions1.90PerShare
1.90
CY2021Q3 clir Stock Issued During Period Value Stock Options Exercised1.90 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.90PerShare
10000
CY2021Q3 clir Shares Issued For Services Per Share
SharesIssuedForServicesPerShare
2.33
CY2021Q3 clir Shares Issued For Services2.33 Per Share
SharesIssuedForServices2.33PerShare
9000
CY2021Q3 clir Apic Share Based Payment Arrangement Net Reversal
ApicShareBasedPaymentArrangementNetReversal
85000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-2353000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9420000
us-gaap Profit Loss
ProfitLoss
-4440000
us-gaap Profit Loss
ProfitLoss
-6665000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
21000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
27000
us-gaap Share Based Compensation
ShareBasedCompensation
307000
us-gaap Share Based Compensation
ShareBasedCompensation
606000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
113000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
215000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
236000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
37000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
251000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
245000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-92000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
161000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-160000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
189000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
441000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-23000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-94000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4264000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5542000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
114000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
69000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
37000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
3900000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3982000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-135000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6539000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5309000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
385000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6539000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5694000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-20000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1727000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7607000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8824000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5880000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8841000
clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
107000
clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
217000
clir Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
91000000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
453000
CY2021Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
1055000
CY2022Q3 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
63000
CY2021Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
77000
CY2022Q3 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
364000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3100000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3300000
CY2022Q3 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
758000
CY2021Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1132000
CY2022Q3 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
695000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
us-gaap Depreciation
Depreciation
19000
us-gaap Depreciation
Depreciation
21000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
364000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
453000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
180000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
419000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
555000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.057
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
49000
us-gaap Operating Lease Cost
OperatingLeaseCost
138000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
66000
us-gaap Operating Lease Cost
OperatingLeaseCost
162000
us-gaap Payments For Rent
PaymentsForRent
185000
us-gaap Payments For Rent
PaymentsForRent
162000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
25000
CY2022Q3 clir Lessee Operating Lease Liability Discounted Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityDiscountedPaymentsRemainderOfFiscalYear
60000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
66000
CY2022Q3 clir Lessee Operating Lease Liability Discounted Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths
134000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
148000
CY2022Q3 clir Lessee Operating Lease Liability Discounted Payments Due Year Two
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearTwo
54000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
64000
CY2022Q3 clir Lessee Operating Lease Liability Discounted Payments Due Year Three
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearThree
58000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
66000
CY2022Q3 clir Lessee Operating Lease Liability Discounted Payments Due Year Four
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearFour
63000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
67000
CY2022Q3 clir Lessee Operating Lease Liability Discounted Payments Due After Year Four
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueAfterYearFour
50000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
51000
CY2022Q3 clir Lessee Operating Lease Liability Discounted Payments Due
LesseeOperatingLeaseLiabilityDiscountedPaymentsDue
419000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
462000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
43000
CY2022Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1125000
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1016000
CY2022Q3 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
101000
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
97000
CY2022Q3 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2021Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1234000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1121000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
416000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
322000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
818000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
38000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
133000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
111000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
79000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
45000
CY2022Q3 clir Finite Lived Intangible Assets Amortization Expense Due After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseDueAfterYearFour
34000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
440000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
324000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
324000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
201000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
201000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
190000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
553000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
278000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1008000
CY2021Q3 clir Cost Of Sales On Losses Contracts
CostOfSalesOnLossesContracts
182000
CY2021Q3 clir Cost Of Goods Sold Loss Related To Delivery And Sale
CostOfGoodsSoldLossRelatedToDeliveryAndSale
96000
us-gaap Contract With Customer Asset Change In Method Credit Loss Expense Reversal
ContractWithCustomerAssetChangeInMethodCreditLossExpenseReversal
86000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
8000
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
284000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
61000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
62500000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000.0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.7764
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0139
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
84000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-85000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
344000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2964000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M20D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
88000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.26
clir Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y3M3D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
230000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.99
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2779000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M28D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1952000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.70
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y29D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
53000
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1100000
CY2021 clir Agreement Term
AgreementTerm
P10Y
CY2022Q3 clir Governmental Grant Income
GovernmentalGrantIncome
12000
clir Governmental Grant Income
GovernmentalGrantIncome
24000
clir Governmental Grant Income
GovernmentalGrantIncome
0

Files In Submission

Name View Source Status
clir-20220930_cal.xml Edgar Link unprocessable
clir-20220930_def.xml Edgar Link unprocessable
clir-20220930_pre.xml Edgar Link unprocessable
clir-20220930x10q_htm.xml Edgar Link completed
clir-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001558370-22-017750-index-headers.html Edgar Link pending
0001558370-22-017750-index.html Edgar Link pending
0001558370-22-017750.txt Edgar Link pending
0001558370-22-017750-xbrl.zip Edgar Link pending
clir-20220930.xsd Edgar Link pending
clir-20220930x10q.htm Edgar Link pending
clir-20220930xex31d1.htm Edgar Link pending
clir-20220930xex31d2.htm Edgar Link pending
clir-20220930xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending